New antibiotic found in human nose

first_imgMANCHESTER, U.K.—You may have heard about drugs disappearing into people’s noses. But at a meeting here this week and in a new paper, scientists presented the opposite: A new antibiotic that has, quite literally, emerged from the human nose. The compound is produced by one species of nose-dwelling bacterium to kill another microbe, which kills thousands of people every year.The study is “yet another demonstration that we should look to nature for solutions to the problems nature throws at us,” says Andrew Read, an evolutionary biologist at Pennsylvania State University, University Park, who was not involved with the work.Any new antibiotic is welcome because the world is running out of these life-saving drugs. But the researchers behind the new finding believe that studying the microbial warfare going on inside our bodies may lead to not just one, but a whole slew of novel drugs. “We’ve found a new concept of finding antibiotics,” Andreas Peschel, a bacteriologist at the University of Tübingen in Germany, said on Tuesday at the EuroScience Open Forum, a biennial science and policy meeting. “We have preliminiary evidence at least in the nose that there is a rich source of many others, and I’m sure that we will find new drugs there.” Sign up for our daily newsletter Get more great content like this delivered right to you! Country Email Peschel and bacteriologist Bernhard Krismer, also at the University of Tübingen, started out investigating why roughly every third person carries a bacterium called Staphylococcus aureus in their nose. Most of the time, S. aureus is harmless, but occasionally, it causes severe, even life-threatening, disease—for instance when it gets into an open wound and causes sepsis. S. aureus is a notorious hospital dweller, and its drug-resistant form, known as MRSA (for methicillin-resistant Staphylococcus aureus) is a major public health problem, killing more than 10,000 people a year in the United States alone.But why do some people carry S. aureus in their nose, whereas others don’t? Analyzing human nasal secretions—also known as snot—Peschel and Krismer found that the nose is not a very hospitable niche for microbes. “If I were a bacterium I would not go into the nose,” Peschel says. “There is nothing there, simply a salty liquid and a tiny amount of nutrients.”Those harsh conditions might lead to fierce competition for resources, the researchers reasoned. So they tested what effect a collection of other Staphylococcus species had on S. aureus. One bacterium, S. lugdunensis, turned out to be very good at preventing S. aureus from growing. The researchers found that the bacterium produced an antibiotic compound and succeeded in synthesizing it in the laboratory. The chemical, which they named lugdunin, inhibited S. aureus from growing in the petri dish, and when applied to the skin of mice infected with S. aureus, it reduced or even eradicated the infection, the team reports today in Nature. It was also effective against antibiotic-resistant strains like MRSA.Just how lugdunin works is unclear. The researchers say that S. aureus did not evolve resistance to it, however, even when exposed to low levels over a period of 30 days.The scientists then analyzed the microbial populations in the noses of 187 hospitalized patients. Sixty of them carried S. aureus and 17 S. lugdunensis; only one patient carried both. That suggests S. lugdunensis is a powerful enemy of S. aureus, the authors say.“This is extremely exciting as it provides evidence that a microbial war is ongoing in our body,” says Jack Gilbert, a microbial ecologist at the University of Chicago in Illinois. On a practical level, he says, the research shows “that certain organisms can be leveraged to create novel drugs that could add to our arsenal of weapons against drug-resistant [microbes].”But using such new weapons may have unintended consequences, warns Peer Bork, a computational biologist at the European Molecular Biology Laboratory in Heidelberg, Germany. “Yes, it’s a cool finding,” he says. But the microbiome is a delicate balance that has evolved over millions of years, he cautions. “It’s more complex than goodies and baddies. Tinkering around might destroy long-evolved community relations.”Peschel does not see any big risks, however. “S. aureus is really the most important pathogen that colonizes human noses,” he says, so if lugdunin could get rid of it, it would be hard to imagine a negative outcome. Theoretically, instead of using the antibiotic, you could also allow S. lugdunensis to colonize patients at risk from S. aureus, he says—a probiotics treatment for the nose. The problem is that S. lugdunensis is itself associated with a range of infections—including of the heart, joints, skin, and eyes—so that strategy could be dangerous. “There may be other bacteria where that is an option,” Peschel says.Read is skeptical of claims that lugdunin may not trigger resistance, because every antibiotic developed so far has run into resistance problems. “Antibiotic use that does not drive resistance is the holy grail,” he says. “Fantastic if lugdunin turns out to be one such case. But history tells us not to hold our breath.”center_img Click to view the privacy policy. Required fields are indicated by an asterisk (*) Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwelast_img

Leave a Reply

Your email address will not be published. Required fields are marked *